(3-Methyl-4-(morpholinosulfonyl)phenyl)boronic acid, 97%, 10g

(R)-2-Amino-2'-hydroxy-1,1'-binaphthyl, 95.0%, 100mg

(R)-1-Morpholinopropan-2-ol, 98%, 500mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucine>98.0%(HPLC)(T)25g

3-Bromo-4-methyl-5-nitro-benzoic acid methyl ester, 95.0%, 250mg

(11bS)-N-(Diphenylmethyl)-N-(i-propyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 97%, 1g

Oxygen bottles acc. to Winkler, 250 to 300 ml, 19/26, 1 Piece

2-[(4-methylbenzyl)amino]ethanol hydrochloride, 95.0%, 1g

Ethyl 2-(adamantan-1-ylamino)-2-oxoacetate, 98%, 100mg

2-[(6-Oxido-6H-dibenzo[c,e][1,2]oxaphosphinin-6-yl)methyl]succinic Acid>98.0%(HPLC)(T)5g

p-Diethynylbenzene, 98.0%, 1g

(4-Methoxy-benzyl)-piperidin-4-yl-amine hydrochloride, 95.0%, 250mg

2,6-Lutidine>98.0%(GC)25mL